GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY)

Clinical trials for GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY) explained in plain language.

Never miss a new study

Get alerted when new GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY) trials appear

Sign up with your email to follow new studies for GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New approach aims to protect hearts of people with type 1 diabetes

Disease control Recruiting now

This early-phase study is investigating whether adding a medication that helps the body remove sugar (an SGLT2 inhibitor) to standard insulin therapy can improve heart and blood vessel health in adults with type 1 diabetes. The goal is to see if this approach, which lowers the am…

Matched conditions: GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY)

Phase: EARLY_PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control

Last updated Apr 04, 2026 06:50 UTC

GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY)

Get alerted when new GLUCOKINASE-MATURITY ONSET DIABETES OF THE YOUNG (GCK-MODY) trials appear

New approach aims to protect hearts of people with type 1 diabetes